$DNTH filed an 8-K with results (Item 2.02) at 4:03 PM ET on Wed, Nov 4.
Vote
DNTH
Dianthus Therapeutics, Inc.About DNTH
Dianthus Therapeutics Inc. is a clinical-stage biotechnology company dedicated to developing potentially best-in-class therapies for patients with severe autoimmune diseases. The company operates as a single segment and has one reportable segment, focusing on creating next-generation treatments to revolutionize the management of severe autoimmune conditions. The team comprises experienced biotech and pharma executives. The pipeline includes the potential of Claseprubart, a next-generation complement therapeutic.
Board
Community opinions, not advice. Posts with a target get a receipt. How receipts work ›